|
1
|
Gao YJ and Zsolt Szabo: Metabolic and
anatomic characteristics of bronchioloalveolar carcinoma on 18F-FDG
PET/CT. Chin J Nucl Med. 29:238–241. 2009.
|
|
2
|
Naidich DP, Bankier AA, MacMahon H,
Schaefer-Prokop CM, Pistolesi M, Goo JM, Macchiarini P, Crapo JD,
Herold CJ, Austin JH and Travis WD: Recommendations for the
management of subsolid pulmonary nodules detected at CT: A
statement from the fleishchner society. Radiology. 266:304–317.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim H, Park CM, Koh JM, Lee SM and Goo JM:
Pulmonary subsolid nodules: What radiologists need to know about
the imaging features and management strategy. Diagn Interv Radiol.
20:47–57. 2014.PubMed/NCBI
|
|
4
|
Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ
and Im JG: Nodular Ground-glass opacity at thin-section CT:
Histologic correlation and evaluation of change at follow up.
Radiographics. 27:391–408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eglinton T, Luck A, Bartholomeusz D,
Varghese R and Lawrence M: Positron-emission tomography/computed
tomography (PET/CT) in the initial staging of primary rectal
cancer. Colorectal Dis. 12:667–673. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung W, Jang JY, Kang MJ, Chang YR, Shin
YC, Chang J and Kim SW: The clinical usefulness of
18F-fluorodeoxyglucose positron emission tomography-computed
tomography (PET-CT) in follow-up of curatively resected pancreatic
cancer patients. HPB (Oxford). 18:57–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mac Manus MP and Hicks RJ: PET scanning in
lung cancer: Current status and future directions. Semin Surg
Oneol. 21:149–155. 2003. View Article : Google Scholar
|
|
8
|
Liu W, Li X, Quan J, Ouyang X and Zheng H:
Diagnostic value of 18F-FDG PET/CT for solitary nodular-type
bronchoalveolar carcinoma. Nan Fang Yi Ke Da Xue Xue Bao.
33:114–116. 2013.(In Chinese). PubMed/NCBI
|
|
9
|
Dalli A, Sen H Selimoglu, Coskunsel M,
Komek H, Abakay O, Sergi C and Tanrikulu A Cetin: Diagnostic value
of PET/CT in differentiating benign from malignant solitary
pulmonary nodules. J BUON. 18:935–941. 2013.PubMed/NCBI
|
|
10
|
Christensen JA, Nathan MA, Mullan BP,
Hartman TE, Swensen SJ and Lowe VJ: Characterization of the
solitary pulmonary nodule: 18F FDG PET versus nodule-enhancement
CT. AJR Am J Roentgenol. 187:1361–1367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collins J and Stern EJ: Ground-glass
opacity at CT: The ABCs. AJR Am J Roentgenol. 169:355–367. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kandemir Z, Sentürk A, Ozdemir E, Yildirim
N, Hasanoğlu HC, Keskin M and Türkölmez S: The evaluation of
hypermetabolic mediastinal-hilar lymph nodes determined by PET/CT
in pulmonary and extrapulmonary malignancies: Correlation with
EBUS-TBNA. Turk J Med Sci. 45:1234–1242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ
and Im JG: Nodular ground-glass opacity at thin-section CT:
Histologic correlation and evaluation of change at follow-up.
Radiographics. 27:391–408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei Z, Xu N, Zhang J, et al: MSCT
diagnosis of unusual interstitial pneumonia. Chin J Mod Med.
22:76–79. 2012.
|
|
15
|
Qi YG, Huang Y, Zheng JS, et al: The
Features and diagnostic value of CT and PET in pneumonia type of
bronchioloalveolar carcinoma. J Clin Radic. 29:187–190. 2010.
|
|
16
|
Guo G, Chen N, Li GF, et al: Complete
video-assisted thoracoscopic surgery for the diagnosis and
treatment of focal ground-glass opacity. Chin J Min Inv Surg.
12:641–643. 2012.
|
|
17
|
Jiang BG and Li L: Characteristics of thin
slice spiral CT imaging in 45 cases of solitary pulmonary nodule.
Chin J Geront. 31:1541–1543. 2011.
|
|
18
|
Porcu P: A look at the national
comprehensive cancer network guidelines for cutaneous lymphomas.
Clin Lymphoma Myeloma Leuk. 10 Suppl 2:S109–S111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin CC, Chen LC, Tseng VS, Yan JJ, Lai WW,
Su WP, Lin CH, Huang CY and Su WC: Malignant pleural effusion cells
show aberrant glucose metabolism gene expression. Eur Respir J.
37:1453–1465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Erasmus JJ, McAdams HP, Rossi SE, Goodman
PC, Coleman RE and Patz EF: FDG PET of pleural effusions in
patients with non-small cell lung cancer. AJR Am J Roentgenol.
175:245–249. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Endo K, Oriuchi N, Higuchi T, Iida Y,
Hanaoka H, Miyakubo M, Ishikita T and Koyama K: PET and PET/CT
using 18 F-FDG in the diagnosis and management of cancer patients.
Int J Clin Oncol. 11:286–296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Glaudemans AW, de Vries EF, Galli F,
Dierckx RA, Slart RH and Signore A: The use of (18)F-FDG-PET/CT for
diagnosis and treatment monitoring of inflammatory and infectious
diseases. Clin Dev Immunol. 2013:6230362013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mi B, Wan W, Yu C, You X, Jiang F and You
Q: The value of extra-lung lesions on ¹8F-FDG PET/CT in improving
diagnosis of lung cancer. Zhongguo Fei Ai Za Zhi. 15:78–83.
2012.(In Chinese). PubMed/NCBI
|
|
24
|
Birim O, Kappetein AP, Stijnen T and
Bogers AJ: Meta-analysis of positron emission tomographic and
computed tomographic imaging in detecting mediastinal lymph node
metastases in nonsmall cell lung cancer. Ann Thorac Surg.
79:375–382. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Waki A, Fujibayashi Y, Yonekura Y, Sadato
N, Ishii Y and Yokoyama A: Reassessment of FDG uptake in tumor
cells: High FDG uptake as a reflection of oxygen-independent
glycolysis dominant energy production. Nucl Med Biol. 24:665–670.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Macheda ML, Rogers S and Best JD:
Molecular and cellular regulation of glucose transporter (GLUT)
proteins in cancer. J Cell Physiol. 202:654–662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arabi M and Piert M: Hypoxia PET/CT
imaging: Implications for radiation oncology. Q J Nucl Mol Imaging.
54:500–509. 2010.
|
|
28
|
Chan WK, Au WY, Wong CY, Liang R, Leung
AY, Kwong YL and Khong PL: Metabolic activity measured by F-18 FDG
PET in natural killer-cell lymphoma compared to aggressive B- and
T-cell lymphomas. Clin Nucl Med. 35:571–575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koiso K, Kakizoe T, Murahashi I, Umeda T
and Ueno A: Studies on the metabolic activities of the bladder
tumors. 2. Studies on the energy metabolism of the bladder tumors
(author's transl). Nihon Hinyokika Gakkai Zasshi. 68:22–32.
1977.(In Japanese).
|
